References
- RaynorDKBlenkinsoppAKnappPA systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicinesHealth Technol Assess2007115iii116017280623
- RaynorDKSavageIKnappPHenleyJWe are the experts: people with asthma talk about their medicine information needsPatient Educ Couns200453216717415140456
- KnappPRaynorDKBerryDCComparison of two methods of presenting risk information to patients about the side effects of medicinesQual Saf Health Care200413317618015175486
- European CommissionA Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human UseBrusselsEuropean Commission Pharmaceutical Committee1998 [cited October 26, 2014]. Available from: http://pharma.be/assets/files/854/854_128901376878944246.pdfAccessed October 26, 2014
- BerryDRaynorTKnappPBerselliniEOver the counter medicines and the need for immediate action: a further evaluation of European Commission recommended wordings for communicating riskPatient Educ Couns200453212913415140451
- BerryDCRaynorDKKnappPCommunicating risk of medication side effects: an empirical evaluation of EU recommended terminologyPsychol Health Med200383251263
- Medicines and Healthcare Products Regulatory AgencyGuideline on Communication of Risks and Benefits in Patient Information Leaflets2005 [cited October 26, 2014]. Available from: http://www.mhra.gov.uk/home/groups/pl-a/documents/websiteresources/con049315.pdfAccessed October 26, 2014
- AslaniPConsumer medicine information conundrumsAust Prescr2007305122124
- Therapeutic Goods Regulation 1990, Australia [Regulation on the Internet]2014 [cited May 4, 2015]. Available from: http://www.comlaw.gov.au/Details/F2014C00898Accessed May 4, 2015
- AslaniPHamrosiKFelettoEInvestigating Consumer Medicine Information (I-CMI) ProjectSydneyThe Pharmacy Guild of Australia, Australian Government Department of Health and Ageing2010
- TongVRaynorDKBlalockSJAslaniPExploring consumer opinions on the presentation of side-effects information in Australian Consumer Medicine Information leafletsHealth Expect2014
- ReynaVFNelsonWLHanPKDieckmannNFHow numeracy influences risk comprehension and medical decision makingPsychol Bull2009135694397319883143
- ReynaVFA theory of medical decision making and health: fuzzy trace theoryMed Decis Making200828685086519015287
- SlovicPFinucaneMLPetersEMacGregorDGRisk as analysis and risk as feelings: some thoughts about affect, reason, risk, and rationalityRisk Anal200424231132215078302
- SlovicPPetersERisk perception and affectCurr Dir Psychol Sci2006156322325
- SlovicPPetersEFinucaneMLMacGregorDGAffect, risk, and decision makingHealth Psychol200524suppl 4S35S4016045417
- ReynaVFBrainerdCJNumeracy, ratio bias, and denominator neglect in judgments of risk and probabilityLearn Individ Differ200818189107
- KruegerRACaseyMAFocus Groups: A Practical Guide for Applied ResearchThousand OaksSage Publications2009
- GreenJThorogoodNQualitative Methods for Health Research3rd edLondonSage Publications Ltd2014
- FestingerLA theory of social comparison processesHum Relat195472117140
- TaylorJSeyed-HosseiniMQuestDFraming the risk of an OTC medication side effectCan Pharm J (Ott)201114413439
- DickinsonRHamrosiKKnappPSuits you? A qualitative study exploring preferences regarding the tailoring of consumer medicines informationInt J Pharm Pract201321420721523419082
- HamrosiKDickinsonRKnappPIt’s for your benefit: exploring patients’ opinions about the inclusion of textual and numerical benefit information in medicine leafletsInt J Pharm Pract201321421622523419118
- SlessDShrenskyRWriting About Medicines for People: Usability Guidelines for Consumer Medicine Information3rd edNorth SydneyAustralian Self Medication Industry2006